# Scientific Skeptic Assessment: TBK1 Loss/Microglial Senescence Hypothesis in ALS
## Executive Summary
The hypothesis proposes a coherent and mechanistically plausible model linking TBK1 loss-of-function mutations to ALS pathogenesis through microglial senescence and SASP. While supported by compelling animal model data and consistent with known roles for TBK1 in inflammatory signaling, this framework faces significant challenges from the prevailing evidence suggesting neuronal autophagy dysfunction as the primary TBK1-dependent pathogenic mechanism. I identify critical gaps in causal evidence, alternative explanations that remain underexplored, and experiments necessary to meaningfully falsify or refine the hypothesis.
---
## 1. Mechanistic Specificity Deficiencies
### 1.1 Definition of "Senescent Transcriptional State"
The hypothesis invokes an "aged/senescent transcriptional signature" without precisely specifying which molecular markers or transcriptional programs constitute this state. This ambiguity creates diagnostic and mechanistic problems:
- **Marker specificity**: Classic senescence markers (p16^INK4a, p21^CIP1, SA-β-gal) are rarely comprehensively assessed in the cited studies. Most transcriptomic signatures labeled as "senescent" rely on overlapping inflammatory gene modules that are also consistent with: (a) chronic inflammatory activation, (b) pyroptotic or necroptotic states, (c) failed phagocytic activation, or (d) simply age